Open Access

Synergistic effects of omega-3 polyunsaturated fatty acids and aspirin in the clinical practice – a narrative review


Cite

Nowak JZ. Przeciwzapalne „prowygaszeniowe” pochodne wielonienasyconych kwasów tłuszczowych omega-3 i omega-6. Postep Hig Med Dosw. 2010;64:115-32.Search in Google Scholar

Davidson MH. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoicacid, docosapentaenoic acid, and eicosapentaenoic acid. Curr Opin Lipidol. 2013;24(6):467-74.Search in Google Scholar

Sicinska P, Koter-Michalik M, Kurowska J, Pytel E. Suplementacja kwasami omega w rożnych chorobach. Postęp Hig Med Dosw. 2015;69:838-52.Search in Google Scholar

Lev EI, Solodky A, Harel N, Mager A, Brosh D, Assali A, et al. Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation. J Am Coll Cardiol. 2010;55(2):114-21.Search in Google Scholar

Poorani R, Bhatt AN, Dwarakanath BS, Das UN. COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance. Eur J Pharmacol. 2016;785:116-32.Search in Google Scholar

Smolik S, Weglarz L. Aspiryna – 115 lat po odkryciu. Ann Acad Med Siles. 2013;67(1):67-73.Search in Google Scholar

Gutiérrez S, Svahn SL, Johansson ME. Effects of omega-3 fatty acids on immune cells. Int J Mol Sci. 2019;20(20):5028.Search in Google Scholar

Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92-101.Search in Google Scholar

Chamani S, Bianconi V, Tasbandi A, Pirro M, Barreto GE, Jamialahmadi T, et al. Resolution of inf lammation in neurodegenerative diseases: The role of resolvins. Mediators of Inflamm. 2020;2020:3267172.Search in Google Scholar

Fritsche KL. The science of fatty acids and inflammation. Adv Nutr. 2015;6:293-301.Search in Google Scholar

Ishihara T, Yoshida M, Arita M. Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis. Int Immunol. 2019;31(9):559-67.Search in Google Scholar

Yazici D, Sezer H. Insulin resistance, obesity and lipotoxicity. Adv Exp Med Biol. 2017;960:277-304.Search in Google Scholar

Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010;142(5): 687-98.Search in Google Scholar

Moradi S, Alivand M, KhajeBishak Y, AsghariJafarabadi M, Alipour M, Chilibeck PD, et al. The effect of omega3 fatty acid supplementation on PPARγ and UCP2 expressions, resting energy expenditure, and appetite in athletes. BMC Sports Sci Med Rehabil. 2021;13(1):48.Search in Google Scholar

Pahlavani M, Ramalho T, Koboziev I, LeMieux MJ, Jayarathne S, Ramalingam L, et al. Adipose tissue inflammation in insulin resistance: review of mechanisms mediating anti-inflammatory effects of omega-3 polyunsaturated fatty acids. J Investig Med. 2017; 65(7):1021-7.Search in Google Scholar

Silver N. Flaxseed oil side effects. Healthline; 2018.Search in Google Scholar

Filipczyk L, Wystrychowski A. Wygaszanie reakcji zapalnej przez pochodne ω-3 i ω 6 wielonasyconych kwasów tłuszczowych. Nefrol Dial Pol. 2011;15:43-52.Search in Google Scholar

Santos HO, Price JC, Bueno A. A beyond fish oil supplementation: the effects of alternative plant sources of omega-3 polyunsaturated fatty acids upon lipid indexes and cardiometabolic biomarkers – an overview. Nutrients. 2020;12(10):3159.Search in Google Scholar

Chouchani ET, Kajimura S. Metabolic adaptation and maladaptation in adipose tissue. Net Metab. 2019;1(2):189-200.Search in Google Scholar

Dutkowska A, Rachon D. Rola kwasków tłuszczowych n-3 oraz n-6 w prewencji chorób układu sercowo-naczyniowego. ChSiN. 2015;12(3):154-9.Search in Google Scholar

Coudray C, Favier A. Determination of salicylate hydroxylation products as an in vivo oxidative stress marker. Free Radic Biol Med. 2000;29:1064-70.Search in Google Scholar

Sankaranarayanan R, Kumar DR, Altinoz MA, Bhat GJ. Mechanisms of colorectal cancer prevention by aspirin – A literature review and perspective on the role of COX-dependent and -independent pathways. Int J Mol Sci. 2020;21(23):9018.Search in Google Scholar

Zajac-Grabiec A, Bartusek K, Sroczynska K, Librowski T, Gdula-Argasinska J. Effect of eicosapentaenoic acid supplementation on murine preadipocytes 3T3-L1 cells activated with lipopolysaccharide and/or tumor necrosis factor-α. Life. 2021;11(9):977.Search in Google Scholar

Broncel M. Zasady skutecznej i bezpiecznej terapii kwasem acetylosalicylowym. The principles of effective and safe therapy with acetylsalicylic acid. Geriatria. 2019;13:50-62.Search in Google Scholar

Das UN. Combination of aspirin with essential fatty acids is superior to aspirin alone to prevent or ameliorate sepsis or ARDS. Lipids Health Dis. 2016;15(1):206.Search in Google Scholar

Schneider TR, Johns CB, Palumbo ML, Murphy KC, Cahill KN, Laidlaw TM. Dietary fatty acid modification for the treatment of aspirin-exacerbated respiratory disease: A prospective pilot trial. J Allergy Clin Immunol Pract. 2018;6(3):825-31.Search in Google Scholar

Cahill KN, Raby BA, Zhou X, Guo F, Thibault D, Baccarelli A, et al. Impaired E Prostanoid2 expression and resistance to Prostaglandin E2 in nasal polyp fibroblasts from subjects with aspirin-exacerbated respiratory disease. Am J Respir Cell Mol Biol. 2016;54(1):34-40.Search in Google Scholar

Levy BD. Resolvin D1 and Resolvin E1 promote the resolution of allergic airway inflammation via shared and distinct molecular counter-regulatory pathways. Front Immunol. 2012;3:390.Search in Google Scholar

Jahabi R, Reheman A, Kulmacz K. Development of poly unsaturated fatty acid derivatives of aspirin for inibition of plate function. J Pharmacol Exp Ther. 2016;359(1):134-41.Search in Google Scholar

Block RC, Dier U, Artero PC, Shearer GC, Kakinami L, Larson MK, et al. The effects of EPA+DHA and aspirin on inflammatory cytokines and angiogenesis factors. World J Cardiovasc Dis. 2012;2(1):14-9.Search in Google Scholar

Block RC, Kakinami L, Jonovich M. The combination of EPA+DHA and low-dose aspirin ingestion reduces platelet function acutely whereas each alone may not in healthy humans. Prostaglandins Leukot Essent Fatty Acids. 2012;87(4-5):143-51.Search in Google Scholar

Thorngren M, Gustafson A. Effects of 11-week increases in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation. Lancet. 1981;2(8257):1190-3.Search in Google Scholar

Westgarth S, Blois SL, Wood RD, Verbrugghe A, Ma DW. Effects of omega-3 polyunsaturated fatty acids and aspirin, alone and combined, on canine platelet function. J Small Anim Pract. 2017;1-9.Search in Google Scholar

Block RC, Holub A, Abdolahi A, Tu XM, Mousa SA, Oda MN. Effects of aspirin in combination with EPA and DHA on HDL-C cholesterol and ApoA1 exchange in individuals with Type 2 diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids. 2017;126:25-31.Search in Google Scholar

Bowman L, Mafham M, Stevens W, Haynes R, Aung T, Chen F, et al. ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes. Am Heart J. 2018;198:135-44.Search in Google Scholar

Wang IE, Yi S, Block RC, Mousa SA. Aspirin and omega-3 polyunsaturated fatty acid use and their interaction in cardiovascular diseases and colorectal adenomas. Nutr Res Rev. 2022;35(2):295-307.Search in Google Scholar

Hirahashi J, Hanafusa N, Wada T, Arita M, Hishikawa K, Hayashi M, et al. Aspirin and eicosapentaenoic acid may arrest progressive IgA nephropathy: A potential alternative to immunosuppression. Internal Med. 2015;54:2377-82.Search in Google Scholar

Niemczyk A, Szejnoga K, Pyryt M, Wichary A, Szywacz A, Grzeszczak W, et al. The genetic basis and diagnosis of IgA nephropathy. Via Medica. 2019;12(4):229-36.Search in Google Scholar

Alexopoulos E, Stangou M, Pantzaki A, Kirmizis D, Memmos D. Treatment of severe IgA nephropathy with omega-3 fatty acids: the effect of a “very low dose” regimen. Ren Fail. 2009;26:453-9.Search in Google Scholar

Hull MA, Sprange K, Hepburn T, Tan W, Shafayat A, Rees CJ, et al. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial. Lancet. 2018;392(10164):2583-94.Search in Google Scholar

Slawek J. Choroba Parkinsona – jak właściwie rozpoznawać, skutecznie i bezpiecznie leczyć? Forum Med Rodz. 2014;8(6):281-91.Search in Google Scholar

Fu Y, Zhen J, Lu Z. Synergetic neuroprotective effect of docosahexaenoic acid and aspirin in SH-Y5Y by Inhibiting miR-21 and activating RXRa and PPARa. DNA Cell Biol. 2017;36(6):482-9.Search in Google Scholar

Sanz M, Del Castillo AM, Jepsen S, Gonzalez-Juanatey JR, D’Aiuto F, Bouchard P, et al. Periodontitis and cardiovascular diseases: Consensus report. J Clin Periodontol. 2020;47(3):268-88.Search in Google Scholar

Castro Dos Santos NC, Andere NMRB, Araujo CF, de Marco AC, Kantarci A, Van Dyke TE, et al. Omega-3 PUFA and aspirin as adjuncts to periodontal debridement in patients with periodontitis and type 2 diabetes mellitus: Randomized clinical trial. J Periodontol. 2020;91(10):1318-27.Search in Google Scholar

Keskiner I, Saygun I, Bal V, Serdar M, Kantarci A. Dietary supplementation with low-dose omega-3 fatty acids reduces salivary tumor necrosis factor-α levels in patients with chronic periodontitis: a randomized controlled clinical study. J Periodontal Res. 2017;52(4):695-703.Search in Google Scholar

Kim DH, Yoo TH, Lee SH, Kang HY, Nam BY, Kwak SJ, et al. Gamma linolenic acid exerts anti-inflammatory and anti-fibrotic effects in diabetic nephropathy. Yonsei Med J. 2012;53(6):1165-75.Search in Google Scholar

eISSN:
2300-6676
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, other, Pharmacology, Toxicology, Pharmacy